Partial federal government shutdown
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
Medication is the first line of treatment for individuals with opioid use disorder (OUD). Opioid Treatment Programs (OTP) provide the only location where individuals can be administered or dispensed all three types of medication for opioid use disorder (MOUD): methadone, buprenorphine products (Suboxone, Subutex), and naltrexone (Vivitrol).
OTPs offer medical and behavioral health services to all patients to facilitate a holistic approach to recovery such as substance use outpatient treatment and Hepatitis C and wound care services.
Looking for Opioid Treatment Programs near you?
OTPs use medications for opioid use disorder (MOUD) — the use of medicines combined with counseling and behavioral therapies — to treat patients diagnosed with opioid use disorders (OUDs).
There are currently three FDA-approved types of evidence-based medications used to treat opioid use disorder: methadone, buprenorphine, and naltrexone.
OTPs are licensed and certified as a behavioral health agency by the Washington State Department of Health (DOH). OTPs must also obtain:
Information about this process, including state laws and regulations, can be found on the DOH OTP webpage.
HCA's Washington State Opioid Treatment Authority office provides oversight for BH-ASO and MCO contracted services.
Email: Jessica Blose
Opioid treatment authority
Phone: 360-643-7850
Email: Sara Multanen-Karr
Opioid Treatment Programs administrator
Phone: 360-643-7106
Email: Lauren Kula
Opioid treatment quality improvement program manager
Phone: 360-742-2182